Healthcare portfolio

We believe our portfolio best meets the varied and often complex needs of patients and societies. Novartis is positioned to lead in innovation, partner with others and offer solutions to patients across a broad healthcare spectrum. In addition, a diverse portfolio reduces financial risk, bringing greater value to those who invest in our company.

Our portfolio, focused on broad areas of healthcare, aims to best meet the evolving needs of patients and societies worldwide.

Novartis is the only company with leading positions in four key areas:

• Pharmaceuticals: Innovative patent-protected medicines
• Vaccines and Diagnostics: Vaccines and diagnostic tools to protect against life-threatening diseases
• Sandoz: Affordable, high-quality generic medicines and biosimilars
• Consumer Health: Strong, trustworthy brands for increasingly knowledgeable consumers: OTC (Over-the-Counter), Animal Health and CIBA Vision

Since Novartis was created in 1996 - when only 45% of net sales came from healthcare – the company has shifted focus to fast-growing areas of healthcare. Our strategy is to provide healthcare solutions that address the evolving needs of patients and societies worldwide.